RCM
Raleigh Capital Management’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.89M | Buy |
77,832
+14,824
| +24% | +$359K | 0.79% | 37 |
|
|
2025
Q1 | $1.6M | Buy |
63,008
+4,881
| +8% | +$124K | 0.72% | 47 |
|
|
2024
Q4 | $1.54M | Sell |
58,127
-2,205
| -4% | -$58.5K | 0.59% | 51 |
|
|
2024
Q3 | $1.75M | Sell |
60,332
-1,496
| -2% | -$43.3K | 0.67% | 37 |
|
|
2024
Q2 | $1.73M | Sell |
61,828
-8,928
| -13% | -$250K | 0.74% | 35 |
|
|
2024
Q1 | $1.96M | Buy |
70,756
+6,275
| +10% | +$174K | 0.85% | 31 |
|
|
2023
Q4 | $1.86M | Sell |
64,481
-2,270
| -3% | -$65.4K | 0.86% | 30 |
|
|
2023
Q3 | $2.21M | Buy |
66,751
+1,484
| +2% | +$49.2K | 1.13% | 19 |
|
|
2023
Q2 | $2.39M | Buy |
65,267
+2,927
| +5% | +$107K | 1.19% | 15 |
|
|
2023
Q1 | $2.54M | Buy |
62,340
+11,800
| +23% | +$481K | 1.26% | 17 |
|
|
2022
Q4 | $2.59M | Buy |
50,540
+8,539
| +20% | +$438K | 1.35% | 16 |
|
|
2022
Q3 | $1.84M | Buy |
42,001
+6,830
| +19% | +$299K | 1.07% | 24 |
|
|
2022
Q2 | $1.84M | Buy |
35,171
+3,252
| +10% | +$170K | 1.05% | 24 |
|
|
2022
Q1 | $1.65M | Buy |
31,919
+31,537
| +8,256% | +$1.63M | 0.9% | 25 |
|
|
2021
Q4 | $23K | Buy |
+382
| New | +$23K | 0.02% | 162 |
|